Navigation Links
Micro vascular Disease Enabled with a Superior Test, Courtesy: Women’s Heart Progra

Advanced diagnostic tests for micro vascular cardiac disease on the lines of what the Cedars-Sinai Medical Center has on offer, will be a good boost// to the researchers to develop novel methods to treat this disease. This disease is found to afflict women much more than men.

“Only in recent years have physicians become aware of micro vascular disease - a dysfunction of the heart’s small arteries - as a significant problem for women,” explains Bairey Merz, who directs Cedars-Sinai’s new Women’s Heart Program and its Preventive and Rehabilitative Cardiac Center. “Now the challenge is to integrate into medical practice systematic ways to diagnose and treat the condition.”

It is estimated that about two to three million women in the U.S. may suffer from microvascular cardiac disease that is not being diagnosed by conventional detection methods. In light of this, Cedars-Sinai’s Women’s Health Program is focusing its expertise on diagnosing and reducing heart disease through a preventive approach that includes state-of-the-art screening and diagnostic testing.

Microvascular coronary artery disease affects the small arteries found throughout the heart, reducing their ability to maintain the oxygen needed by the heart muscle to function properly. The usual tests to diagnose coronary heart disease – electrocardiogram (EKG), exercise stress test, echocardiogram and angiogram – test for dysfunction in the large arteries. Until recently, there was not an accurate diagnostic test for disease in the small arteries.

A new, pharmacological stress test for microvascular disease - an acetylcholine endothelial function and adensosine coronary flow reserve test - is now available at Cedars-Sinai’s Cardiovascular Interventional Center and promises to “greatly enhance our ability to diagnose and treat women with ischemic heart disease,” says Bairey Merz.

During the two-step test, the drug adenosine, which normally causes the sm
'"/>




Page: 1 2

Related medicine news :

1. Micro-camera provides new breast imaging technique
2. Microchip gives blind a chance of sight
3. Microchip gives blind a chance of sight
4. Microscopic lens monitors heart problems
5. Microwave radiation has no hazards
6. Bioengineering production strains - Microbia develops new methods
7. MicroRNA provides new insight into birth defects
8. Microscopic Nanobombs Blow Apart Breast Cancer Cells
9. Microbicides could serve to materialise women empowerment in the years to come
10. Anti-Microbial Coating For Use Over Biomedical Devices Developed
11. Contaminated Land Can Be Cleaned By Micro-Organisms
Post Your Comments:
(Date:5/16/2008)...National HIV Vaccine Awareness Day, May,18, WASHI...x years into the,AIDS epidemic, someone is newly i...unday, May 18, HIV Vaccine Awareness Day, AIDS Act... Institute of Allergy and Infectious,Disease (NIAI...s everyone,to help end the AIDS epidemic by partic...
(Date:5/16/2008)...untsworth plc (LSE: HNT), "the Group",a leading i...nications,group headquartered in London, released ...Group,s performance in the first quarter 2008 (the...follows below., 15 May 2008, ...erim Management Statement, Record net ...
(Date:5/16/2008)... More in 2007, WASHINGTON, May 16 /PRNewswire-USN...cancer deaths, the National Cancer Institute (NCI)...in lung cancer research in 2007,according to upda...) today., The two other federal agencies with sig...isease Control and Prevention (CDC) and the,Depart...
(Date:5/16/2008)...Comprehensive Income increased 42% to $9.7 million... - 2007 Gross Margin of 76%, - Product Sales Back... million from $2.4 million as of December 31, 200...stCall/ -- Huiheng,Medical, Inc. ("Huiheng" or the...sed leader in the development, sales and support o...
Breaking Medicine News(10 mins):Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6
...n for cancer, anyone? Yes, Oxford University resea...can prevent bowel cancer developing . Taking a dos...tion. Long-term aspirin use is generally not back...mach problems, but the team said it could benefit ...
...a research reveals that two thirds of those who ta...delines before doing so. In other words , those us...so on the basis of blind faith and do not care to ...ms or seek evidence based results. The researcher...
...S federal receiver Robert Sillen, hired to improve...bitious turnaround plan for his jurisdiction. Ac... the unconscionable human suffering" in prison and...es from diseases carried by inmates cycling in and...
...g man working as a cleaner for a Tasmanian school ...pturing children in the bathroom on film , and mak... of Hobart pleaded guilty to three counts of indec...child exploitation material, and one count of poss...
Other Medicine News:Health News:Aspirin can Prevent Bowel Cancer, Says UK Study 2Health News:Blind Faith Dictates Use Of Herbal Supplements In Many 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 3
(Date:5/15/2008)...ch, a publishing and,information services company ...finds that investigative sites are required to lea... More than 75% of respondents to a recent,CenterWa... three or more,EDC systems. In addition, a majorit...aining had improved., State of the Clinical Trial...
(Date:5/15/2008)...Call/ -- Novavax, Inc. (Nasdaq:,NVAX) today announ...I/IIa,study of its pandemic influenza vaccine incl...able interim results from the first phase of the s... adult volunteers, were,reported in December 2007....s well tolerated and immunogenic at the 15 microgr...
(Date:5/15/2008)...tions Blue Cross Blue Shield of Michigan to W... HealthLeaders-InterStudy, NA...rs-InterStudy, the,leading provider of managed car... continues to stagnate in Michigan, Blue Cross Blu...all of its competitors to weather the,economic sto...
(Date:5/15/2008)... Genous, Boston Scientific,s ...eal-World Use of Genous, Stent,s Performance in P...l-Antiplatelet Ther...usNeich today announced,that multiple clinical dat...port the use of the company,s Genous Bio-engineere...
Breaking Medicine Technology:CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Lauren Marangell M D to Join Lilly 3B Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar 1723 1Lauren Marangell M D to Join Lilly 3B Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar 1723 2CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 1CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 2CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 3GrantAdler Shipping Novel Implantable Vascular Access Port 1719 1GrantAdler Shipping Novel Implantable Vascular Access Port 1719 2Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 1Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 2Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 3
...re-FirstCall/ --,Schering-Plough Corporation annou...ts novel oral thrombin receptor antagonist (TRA),S...entific Sessions,of the of Cardiology (ACC.07)/Inn...n New Orleans. The Phase II trial, referred to,as ...oronary,Intervention (TRA-PCI) trial, has been acc...
...an TNFa, LAUSANNE, Switzerland, March 12, 2007 /PR...al independent biopharmaceutical,development compa...nditions, announces the presentation of preclinica... Debio-0512 as an anti-TNFa,therapeutic vaccine, t...ls of acute and chronic inflammation. Debio-0512 i...
Other Medicine Technology:Schering-Plough Announces Presentation of Phase II Trial Results,for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual,Meeting of The American College of Cardiology/i2 Summit 2Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2
...ystem treats female urinary stress incontinence (S...er a suprapubic (BioArcTM SP) or a transobturator ...e hybrid system combining synthetic and biologic m...ailable. The BioArc utilizes a polypropylene mesh ...
...ing System utilizes a suprapubic approach to treat...l hypermobility and/or intrinsic sphincter deficie... needles and a self-fixating sling with a resorbab...ve tension refinement without mesh distortion, as ...
...Ultra Sling is a minimally invasive treatment for ...repair surgery can be performed at the same time. ...e a sling, the In-Fast Ultra inserter is used to d...rior aspect of the pubic bone. Each screw has a su...
Proven tension-free sling technology marries with the well-researched Pelvicol® porcine acellular collagen matrix sling, for exceptional resultsby design. Natural tissue-to-tissue contact between
Medicine Products: